Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Translation

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...

Translation

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

General Transcription Factors

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

Mutations

Mutations

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the contributions of noncoding RNAs in acute myeloid leukemia.

Blood neoplasia·2026

Same author

Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis.

bioRxiv : the preprint server for biology·2026

Same author

Loss of cystathionine-β-synthase contributes to elevated OXPHOS, a vulnerability in Ara-C-resistant Myeloid Leukemia in Down syndrome.

Biochemical pharmacology·2026

Same author

Ultra-deep duplex sequencing reveals unique features of somatic evolution in the normal tissues of a family with Li-Fraumeni syndrome.

bioRxiv : the preprint server for biology·2026

Same author

The GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis.

Blood·2026

Same author

FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome.

The Journal of clinical investigation·2026

Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026

Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026

Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026

Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026

Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026

Same journal

A step toward streamlining HIT diagnosis.

Blood·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

GATA factor mutations in hematologic disease.

John D Crispino¹, Marshall S Horwitz²

¹Division of Hematology/Oncology, Northwestern University, Chicago, IL; and.

|February 10, 2017

Summary

This summary is machine-generated.

Mutations in GATA1 and GATA2 transcription factors are linked to various blood disorders, including anemias and leukemias. Understanding these genetic links is crucial for developing targeted therapies for hematologic conditions.

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Related Experiment Videos

Last Updated: Mar 7, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Area of Science:

Hematology
Molecular Biology
Genetics

Background:

GATA transcription factors are vital for cell development, particularly in hematopoietic lineages.
GATA1 and GATA2 are critical for normal hematopoiesis.
Mutations in GATA1 and GATA2 are implicated in a spectrum of blood disorders.

Purpose of the Study:

To review hematopoietic disorders associated with mutations in GATA1 and GATA2.
To highlight the critical roles of GATA1 and GATA2 in blood development and disease.
To underscore the need for targeted therapies for these transcription factors.

Main Methods:

Literature review of studies on GATA1 and GATA2 mutations in hematopoietic disorders.
Analysis of the clinical manifestations and genetic basis of associated blood diseases.
Synthesis of information on the role of GATA factors in hematopoiesis.

Main Results:

GATA1 mutations are associated with Diamond-Blackfan anemia, acute megakaryoblastic leukemia, and congenital dyserythropoietic anemias.
GATA2 germ line mutations cause GATA2 deficiency syndrome.
Acquired GATA2 mutations are found in myelodysplastic syndrome, acute myeloid leukemia, and chronic myeloid leukemia.
The prevalence of these mutations in blood disorders emphasizes the importance of GATA factors.

Conclusions:

GATA1 and GATA2 are essential regulators of hematopoiesis.
Dysregulation of GATA1 and GATA2 through mutations leads to diverse and severe blood disorders.
Targeted therapeutic strategies for GATA transcription factors are warranted.